The companies say the regulatory conditions of Novo Holdings’ $16.5bn deal with Catalent have been met 

All regulatory closing conditions related to Novo Holdings’ $16.5bn acquisition of US drugmaker Catalent the companies said on Saturday that the deal has been completed, adding that it is expected to close in the coming days.

Teile diesen Beitrag:

BELIEBTE BEITRÄGE
FOLGEN SIE UNS
Like uns auf Facebook
Folge uns auf Twitter
Abonniere unseren Kanal
Tick Tack
LIVEÜBERTRAGUNG